Neonatal jaundice. Neonatal jaundice from other specified causes
Conditions
Interventions
Intervention 1: One hundred fifty neonates with hyperbilirubinemia who were admitted at neonatal ward of Besat hospital of Hamedan, Iran and who are breast-fed were divided to two groups. seventy five
Treatment - Drugs
Early detection
One hundred fifty neonates with hyperbilirubinemia who were admitted at neonatal ward of Besat hospital of Hamedan, Iran and who are breast-fed were divided to two groups. seventy five neonates in int
One hundred fifty neonates with hyperbilirubinemia who were admitted at neonatal ward of Besat hospital of Hamedan, Iran and who are breast-fed were divided to two groups. seventy five neonates in con
Sponsors
Hamadan University Of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria:Healthy term breast-fed infants weighing 2.5 to 4 Kg after 36 hours until 14 days developed jaundice and phototherapy indicated. Exclusion criteria:pre-and post term infants, formula feeding, the presence of any malformations and associated diseases such as sepsis,weighing less than 2.5 and more than 4 kg; neonates developed jaundice after 14 days, who need Intensive phototherapy or exchange ; ABO or RH incompatibility ;presence direct hyperbilirubinemia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indirect bilirubin. Timepoint: During 24, 48 and 72 hours after beginning of phototherapy. Method of measurement: Measuring serum bilirubin(diazo method). | — |
Secondary
| Measure | Time frame |
|---|---|
| Age. Timepoint: Between 2 and 14 days of old age. Method of measurement: Since birthday.;Duration of hospitalization. Timepoint: 24,48 and 72 hours after phototherapy. Method of measurement: days.;Sex. Timepoint: Beginning of study. Method of measurement: Physical examination.;Blood group. Timepoint: Beginning of study. Method of measurement: Laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Fatemeh Eghbalian
Hamedan University of medical science
Outcome results
None listed